Department of Gynecology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Front Endocrinol (Lausanne). 2023 Aug 2;14:1136121. doi: 10.3389/fendo.2023.1136121. eCollection 2023.
To evaluate the clinical efficacy of acupuncture for the treatment of diminished ovarian reserve (DOR) based on the existing randomized controlled trials (RCTs).
Nine databases from their inception to December 6th, 2022, were comprehensively searched to retrieve RCTs related to the clinical efficacy of acupuncture for the treatment of DOR. The outcomes of interest were sex hormones level and antral follicle count (AFC). Risk of Bias (RoB) was adopted to assess the quality of the included trials.
A total of 13 RCTs involving 787 patients were included in this meta-analysis. The review of available evidence revealed acupuncture produced a significant efficacy in decreasing follicle-stimulating hormone (FSH) levels (SMD = -1.07, 95%CI [-1.79, -0.36], = 0.003), FSH/LH ratio (MD = -0.31, 95%CI [-0.54, -0.09], = 0.006) and increasing anti-Müllerian hormone (AMH) levels (SMD = 0.25, 95%CI [-0.00, 0.49], = 0.05), along with AFC (MD = 1.87, 95%CI [0.96, 2.79], < 0.0001) compared to controls. Compared with electro-acupuncture treatment, manual acupuncture was superior in reducing FSH levels, FSH/LH ratio, and increasing AMH levels and AFC ( < 0.05). A notable association was also seen when acupuncture was combined with traditional Chinese medicine therapy for improving FSH levels, FSH/LH ratio, and AFC ( < 0.05). Besides, a high dose of acupuncture (≥10 acupoints) was more conducive to ameliorating FSH levels, FSH/LH ratio, and AFC ( < 0.05) than a low dose of acupuncture (<10 acupoints). Substantial heterogeneity existed among studies.
Acupuncture may have significant clinical potential for patients with DOR in terms of improving sex hormones level and increasing AFC, although the evidence is drawn with high heterogeneity. This finding suggests that more rigorous trials conducted in diverse regions worldwide are necessary to identify the efficacy of acupuncture for patients diagnosed with DOR.
https://www.crd.york.ac.uk, identifier CRD42023402336.
基于现有随机对照试验(RCT)评估针灸治疗卵巢储备功能降低(DOR)的临床疗效。
全面检索从建库至 2022 年 12 月 6 日的 9 个数据库,以获取与针灸治疗 DOR 的临床疗效相关的 RCT。主要结局指标为性激素水平和窦卵泡计数(AFC)。采用偏倚风险(RoB)评估纳入试验的质量。
本荟萃分析共纳入 13 项 RCT,共计 787 例患者。现有证据表明,针灸在降低卵泡刺激素(FSH)水平[SMD=-1.07,95%CI(-1.79,-0.36), =0.003]、FSH/LH 比值[MD=-0.31,95%CI(-0.54,-0.09), =0.006]和增加抗苗勒管激素(AMH)水平[SMD=0.25,95%CI(-0.00,0.49), =0.05]方面具有显著疗效,同时也能提高 AFC(MD=1.87,95%CI[0.96,2.79], < 0.0001)。与对照组相比,与电针治疗相比,手针在降低 FSH 水平、FSH/LH 比值、增加 AMH 水平和 AFC 方面更具优势( < 0.05)。当针灸与中药疗法联合使用时,也可以改善 FSH 水平、FSH/LH 比值和 AFC( < 0.05)。此外,高剂量(≥10 个穴位)的针灸比低剂量(<10 个穴位)更有利于改善 FSH 水平、FSH/LH 比值和 AFC( < 0.05)。研究之间存在显著的异质性。
针灸可能对 DOR 患者的性激素水平和 AFC 有显著的临床改善作用,尽管证据存在高度异质性。这一发现表明,需要在全球不同地区开展更多严格的试验,以确定针灸对 DOR 患者的疗效。
https://www.crd.york.ac.uk,注册号 CRD42023402336。